These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 10809212

  • 1. Marrow toxicity of 33P-versus 32P-orthophosphate: implications for therapy of bone pain and bone metastases.
    Goddu SM, Bishayee A, Bouchet LG, Bolch WE, Rao DV, Howell RW.
    J Nucl Med; 2000 May; 41(5):941-51. PubMed ID: 10809212
    [Abstract] [Full Text] [Related]

  • 2. Marrow-sparing effects of 117mSn(4+)diethylenetriaminepentaacetic acid for radionuclide therapy of bone cancer.
    Bishayee A, Rao DV, Srivastava SC, Bouchet LG, Bolch WE, Howell RW.
    J Nucl Med; 2000 Dec; 41(12):2043-50. PubMed ID: 11138691
    [Abstract] [Full Text] [Related]

  • 3. Biologic dosimetry of bone marrow: induction of micronuclei in reticulocytes after exposure to 32P and 90Y.
    Lenarczyk M, Goddu SM, Rao DV, Howell RW.
    J Nucl Med; 2001 Jan; 42(1):162-9. PubMed ID: 11197968
    [Abstract] [Full Text] [Related]

  • 4. Considerations in the selection of radiopharmaceuticals for palliation of bone pain from metastatic osseous lesions.
    Bouchet LG, Bolch WE, Goddu SM, Howell RW, Rao DV.
    J Nucl Med; 2000 Apr; 41(4):682-7. PubMed ID: 10768569
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Biological dosimetry of bone marrow for incorporated yttrium-90.
    Goddu SM, Howell RW, Giuliani DC, Rao DV.
    J Nucl Med; 1998 Mar; 39(3):547-52. PubMed ID: 9529309
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. S values for radionuclides localized within the skeleton.
    Bouchet LG, Bolch WE, Howell RW, Rao DV.
    J Nucl Med; 2000 Jan; 41(1):189-212. PubMed ID: 10647623
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Fractionated radioimmunotherapy of intraperitoneally growing ovarian cancer in nude mice with 211At-MX35 F(ab')2: therapeutic efficacy and myelotoxicity.
    Elgqvist J, Andersson H, Bäck T, Claesson I, Hultborn R, Jensen H, Lindegren S, Olsson M, Palm S, Warnhammar E, Jacobsson L.
    Nucl Med Biol; 2006 Nov; 33(8):1065-72. PubMed ID: 17127181
    [Abstract] [Full Text] [Related]

  • 13. Oligoradionuclidetherapy using radiolabelled antisense oligodeoxynucleotide phosphorothioates.
    Kairemo KJ, Tenhunen M, Jekunen AP.
    Anticancer Drug Des; 1996 Sep; 11(6):439-49. PubMed ID: 8836109
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A three-dimensional transport model for determining absorbed fractions of energy for electrons within trabecular bone.
    Bouchet LG, Jokisch DW, Bolch WE.
    J Nucl Med; 1999 Nov; 40(11):1947-66. PubMed ID: 10565793
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Concerning the health effects of internally deposited radionuclides.
    Raabe OG.
    Health Phys; 2010 Mar; 98(3):515-36. PubMed ID: 20147792
    [Abstract] [Full Text] [Related]

  • 19. A mouse bone marrow dosimetry model.
    Muthuswamy MS, Roberson PL, Buchsbaum DJ.
    J Nucl Med; 1998 Jul; 39(7):1243-7. PubMed ID: 9669402
    [Abstract] [Full Text] [Related]

  • 20. A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)Lu.
    Konijnenberg MW, Bijster M, Krenning EP, De Jong M.
    J Nucl Med; 2004 Jul; 45(7):1260-9. PubMed ID: 15235075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.